Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.
The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...
A new study has punctured a longstanding assumption about the source of the most common type of DNA mutation seen in the genome--one that contributes to many genetic diseases, including cancer. A ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
inews.co.uk on MSN
I’ve got the breast cancer gene but had to wait three years for surgery
Thousands of women with a cancer-causing genetic mutation are facing an agonising wait for a mastectomy, due to a backlog ...
New study shows that in women with BRCA1 or BRCA2 mutations, their breast cells already carry a clear pattern of DNA “damage ...
Hundreds of people filled the Hollywood Broadwalk on Saturday for the Waves of Hope 5K, an annual walk and run raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback